Predictive Ability of a Clinical-Genetic Risk Score for Venous Thromboembolism in Northern and Southern European Populations
Authors:
Open Access
- 4 July 2021
- journal article
- research article
- Published by Georg Thieme Verlag KG in TH Open
- Vol. 05 (03) , e303-e311
Abstract
Venous thromboembolism (VTE) is a complex, multifactorial problem, the development of which depends on a combination of genetic and acqfiguired risk factors. In a Spanish population, the Thrombo inCode score (or TiC score), which combines clinical and genetic risk components, was recently proven better at determining the risk of VTE than the commonly used model involving the analysis of two genetic variants associated with thrombophilia: the Factor V Leiden (F5 rs6025) and the G20210A prothrombin (F2 rs1799963).The aim of the present case–control study was to validate the VTE risk predictive capacity of the TiC score in a Northern European population (from Sweden).The study included 173 subjects with VTE and 196 controls. All were analyzed for the genetic risk variants included in the TiC gene panel. Standard measures —receiver operating characteristic (ROC) area under the curve (AUC), sensitivity, specificity, and odds ratio (OR)—were calculated.The TiC score returned an AUC value of 0.673, a sensitivity of 72.25%, a specificity of 60.62%, and an OR of 4.11. These AUC, sensitivity, and OR values are all greater than those associated with the currently used combination of genetic variants. A TiC version adjusted for the allelic frequencies of the Swedish population significantly improved its AUC value (0.783).In summary, the TiC score returned more reliable risk estimates for the studied Northern European population than did the analysis of the Factor V Leiden and the G20210A genetic variations in combination. Thus, the TiC score can be reliably used with European populations, despite differences in allelic frequencies.Keywords
This publication has 23 references indexed in Scilit:
- Predicting venous thrombosis in women using a combination of genetic markers and clinical risk factorsJournal of Thrombosis and Haemostasis, 2014
- ThrombosisArteriosclerosis, Thrombosis, and Vascular Biology, 2014
- Multilocus Genetic Risk Scores for Venous Thromboembolism Risk AssessmentJournal of the American Heart Association, 2014
- Epidemiology of first and recurrent venous thromboembolism: A population-based cohort study in patients without active cancerThrombosis and Haemostasis, 2014
- Allele frequency distribution of 1691G>A F5 (which confers Factor V Leiden) across Europe, including Slavic populationsJournal of Applied Genetics, 2013
- Multiple SNP testing improves risk prediction of first venous thrombosisBlood, 2012
- Economic Burden of Venous Thromboembolism in Hospitalized PatientsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2009
- Post‐thrombotic syndrome: prevalence, prognostication and need for progressBritish Journal of Haematology, 2009
- Genetic Susceptibility to Thrombosis and Its Relationship to Physiological Risk Factors: The GAIT StudyThe American Journal of Human Genetics, 2000
- Sampling variability of nonparametric estimates of the areas under receiver operating characteristic curves: An updateAcademic Radiology, 1997